The most active researchers, institutions, and subtopics in Melanoma / Checkpoint Inhibitors, from recent PubMed records. Public authorship only, every figure verifiable by PMID.
Analyzed 600 recent PubMed papers (2021-2026) matching "melanoma immune checkpoint inhibitor". Source: NLM PubMed. Generated July 2026.
| # | Researcher | Affiliation | Papers |
|---|---|---|---|
| 1 | Schadendorf Dirk | University Hospital Essen | 9 |
| 2 | Lorigan Paul | The Christie NHS Foundation Trust | 7 |
| 3 | Gebhardt Christoffer | University Medical Center Hamburg-Eppendorf | 7 |
| 4 | Helgadottir Hildur | Karolinska Institutet | 7 |
| 5 | Robert Caroline | Gustave Roussy | 6 |
| 6 | Meier Friedegund | Technische Universität Dresden | 6 |
| 7 | Boutros Andrea | University of Genoa | 5 |
| 8 | Zimmer Lisa | University Hospital Essen | 5 |
| 9 | Livingstone Elisabeth | University Hospital Essen | 5 |
| 10 | Gogas Helen | Laikon General Hospital | 5 |
| 11 | Dummer Reinhard | University Hospital Zurich | 5 |
| 12 | Lee Rebecca | The Christie NHS Foundation Trust | 4 |
| 13 | Davar Diwakar | University of Pittsburgh | 4 |
| 14 | Birbrair Alexander | University of Wisconsin-Madison | 4 |
| 15 | Karapetyan Lilit | H. Lee Moffitt Cancer Center and Research Institute | 4 |
| 16 | Kött Julian | University Medical Center Hamburg-Eppendorf | 4 |
| 17 | Geidel Glenn | University Medical Center Hamburg-Eppendorf | 4 |
| 18 | Ny Lars | University of Gothenburg | 4 |
Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.
Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the (2026) · PMID 42476727
Neoadjuvant Immune Therapy in Patients With Melanoma: Response and Toxicity in a Non-Clinical Trial Setting. (2026) · PMID 42473289
Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from (2026) · PMID 42471484
Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. (2026) · PMID 42465753
PSGL-1 blockade delays relapse to BRAF/MEK inhibition in cutaneous melanoma. (2026) · PMID 42465267
A full Melanoma / Checkpoint Inhibitors brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.